RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MTNB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Wednesday for Matinas Biopharma Holdings Inc stock after gaining 1.47%
(Updated on Mar 27, 2024)

Buy or Hold candidate since Feb 15, 2024 Gain 32.01% PDF

The Matinas Biopharma Holdings Inc stock price gained 1.47% on the last trading day (Wednesday, 27th Mar 2024), rising from $0.286 to $0.290. During the last trading day the stock fluctuated 6.39% from a day low at $0.277 to a day high of $0.295. The price has risen in 6 of the last 10 days and is up by 13.69% over the past 2 weeks. Volume fell on the last day by -229 thousand shares and in total, 941 thousand shares were bought and sold for approximately $272.74 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 36.03% during the next 3 months and, with a 90% probability hold a price between $0.337 and $0.423 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MTNB Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Friday, March 15, 2024, and so far it has fallen -3.37%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. The Matinas Biopharma Holdings Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.283 and $0.255. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Matinas Biopharma Holdings Inc stock

Matinas Biopharma Holdings Inc finds support from accumulated volume at $0.278 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0177 between high and low, or 6.39%. For the last week the stock has had daily average volatility of 21.15%.

Our recommended stop-loss: $0.278 (-4.15%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (MTNB) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Matinas Biopharma Holdings Inc to open at $0.287, and during the day (based on 14 day Average True Range), to move between $0.257 and $0.323, which gives a possible trading interval of +/-$0.0333 (+/-11.48%) up or down from last closing price. If Matinas Biopharma Holdings Inc takes out the full calculated possible swing range there will be an estimated 22.97% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.290 (0.10%) than the support at $0.278 (4.10%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Matinas Biopharma Holdings Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Matinas Biopharma Holdings Inc stock to perform well in the short-term.

Current score: 2.272 Buy Candidate Unchanged

Predicted Opening Price for Matinas Biopharma Holdings Inc of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$0.287 ( 0.93%) $0.290

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MTNB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.305 5.17 %
R2 0.298 2.84 %
R1 0.294 1.40 %
Current price: 0.290
Support S1 0.280 -3.26 %
S2 0.276 -4.70 %
S3 0.270 -7.04 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.300 3.48 %
R2 0.291 0.483 %
R1 0.290 0.103 %
Current price 0.290
Support S1 0.278 -4.10%
S2 0.239 -17.59%
S3 0.227 -21.87%

FAQ

What is the symbol for Matinas Biopharma Holdings Inc Stock and on which exchange is it traded?
The symbol for Matinas Biopharma Holdings Inc is MTNB and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Matinas Biopharma Holdings Inc Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Matinas Biopharma Holdings Inc stock to perform well in the short-term.

How to buy Matinas Biopharma Holdings Inc Stock?
Matinas Biopharma Holdings Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Matinas Biopharma Holdings Inc Stock.

What's the current price of Matinas Biopharma Holdings Inc Stock?
As of the end of day on the 2024-03-27, the price of an Matinas Biopharma Holdings Inc (MTNB) share was $0.290.

What is the 52-week high and low for Matinas Biopharma Holdings Inc Stock?
The 52-week high for Matinas Biopharma Holdings Inc Stock is $0.88 and the 52-week low is $0.112.

What is the market capitalization of Matinas Biopharma Holdings Inc Stock?
As of the 2024-03-27, the market capitalization of Matinas Biopharma Holdings Inc is 62.985M.

When is the next earnings date for Matinas Biopharma Holdings Inc?
The upcoming earnings date for Matinas Biopharma Holdings Inc is Mar 27, 2024.
Click to get the best stock tips daily for free!

About Matinas Biopharma Holdings Inc

Matinas Biopharma Holdings Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is LYPDISO, a presc... MTNB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT